STATE STREET CORP - ONCOMED PHARMACEUTICALS INC ownership

ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 42 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ONCOMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$11,000
+37.5%
10,1890.0%0.00%
Q4 2018$8,000
-88.1%
10,189
-67.6%
0.00%
Q3 2018$67,000
-2.9%
31,447
+5.9%
0.00%
Q2 2018$69,000
-8.0%
29,695
+24.6%
0.00%
Q1 2018$75,000
-11.8%
23,841
+15.4%
0.00%
Q4 2017$85,000
+44.1%
20,667
+57.8%
0.00%
Q3 2017$59,000
+34.1%
13,1000.0%0.00%
Q2 2017$44,000
-98.6%
13,100
-96.3%
0.00%
Q1 2017$3,250,000
+23.7%
352,312
+3.2%
0.00%
Q4 2016$2,628,000
-22.1%
341,271
+15.6%
0.00%
Q3 2016$3,373,000
+3.4%
295,100
+11.4%
0.00%
Q2 2016$3,261,000
+36.1%
264,839
+11.8%
0.00%
Q1 2016$2,396,000
-52.2%
236,832
+6.5%
0.00%
-100.0%
Q4 2015$5,013,000
+54.0%
222,314
+13.3%
0.00%
Q3 2015$3,256,000
-33.8%
196,158
-11.1%
0.00%
-100.0%
Q2 2015$4,919,000
+1.6%
220,683
+17.5%
0.00%
Q1 2015$4,843,000
+16.4%
187,890
-1.8%
0.00%
Q4 2014$4,162,000
+23.1%
191,404
+7.2%
0.00%
Q3 2014$3,380,000
-10.8%
178,565
+9.8%
0.00%
Q2 2014$3,790,000
+55.8%
162,574
+124.9%
0.00%
Q1 2014$2,432,000
+29.7%
72,285
+13.8%
0.00%
Q4 2013$1,875,000
+293.1%
63,519
+104.2%
0.00%
Q3 2013$477,00031,1000.00%
Other shareholders
ONCOMED PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
BVF INC/IL 4,042,989$8,571,0000.75%
NEXTHERA CAPITAL LP 634,715$1,346,0000.26%
Endurant Capital Management LP 219,114$465,0000.21%
Birchview Capital, LP 118,689$252,0000.16%
Perceptive Advisors 2,620,897$5,556,0000.15%
Alambic Investment Management, L.P. 53,972$114,0000.09%
Sofinnova Investments, Inc. 395,744$839,0000.08%
Kazazian Asset Management, LLC 31,475$67,0000.06%
Broadfin Capital, LLC 200,000$424,0000.06%
ESSEX INVESTMENT MANAGEMENT CO LLC 96,639$205,0000.02%
View complete list of ONCOMED PHARMACEUTICALS INC shareholders